ArticleEuropean radiology2026
Pain relief after CT-guided pars injections in lumbar spondylolysis: analysis of MRI findings and CT-contrast distribution.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multifidus fatty infiltration and vertebral translation are key factors associated with movement-related low back pain in L5 isthmic spondylolisthesis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo analyze pain relief in spondylolysis patients with chronic lower back pain (CLBP) after CT-guided bilateral pars injections and investigate MRI findings and CT-contrast distribution as predictors of successful pain relief. MATERIALS AND
methodsPatients with bilateral spondylolysis and CLBP receiving CT-guided pars injections were assessed for pain relief 15 min and 1 month post-injection, using a numeric rating scale (NRS) and percentage pain reduction (PPR). Two radiologists assessed lumbar findings on prior MRI and CT-contrast distribution during injection. Successful pain relief was defined as PPR ≥ 50%. Logistic regression was used to investigate imaging predictors of successful pain relief.
resultsIn 134 patients (mean age 43.9 ± 16.2 years), average NRS pain score dropped from 5.7 at baseline to 3.7 (PPR 34 ± 47.3%) 15 min post-injection, and to 3.2 (PPR 48 ± 43%) 1-month post-injection (all p < 0.001). At 15 min, 56/134 patients (42%) and at 1-month post-injection, 73/134 patients (55%) reported PPR ≥ 50%. Isthmic bone marrow edema (BME) was the only MRI predictor associated with successful pain relief (all p ≤ 0.006). Patients with isthmic BME were 6-9 times more likely to show successful pain relief 15 min post-injection, and 2-3 times more likely to show successful pain relief 1 month post-injection (all p ≤ 0.046). CT-contrast distribution did not correlate with pain relief (all p ≥ 0.27).
conclusionPars injections allowed successful pain relief in 55% of spondylolysis patients after 1 month, with a PPR of 48% on average from baseline. Isthmic BME was an important MRI predictor of successful pain relief for pars injections, whereas CT-contrast distribution was not. KEY POINTS: Question Imaging predictors of successful pain relief in lumbar spondylolysis patients with CLBP receiving bilateral pars injections are unknown. Findings Isthmic BME on MRI was a significant predictor of successful pain relief immediately and 1-month post-injection. CT-contrast distribution did not influence pain relief. Clinical relevance CT-guided pars injections offer successful pain relief in spondylolysis patients with CLBP. Isthmic BME on MRI is a significant predictor for successful pain relief, whereas CT-contrast distribution during injection is not.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.